Drug
oglufanide disodium
oglufanide disodium is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
2
67%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
completed133%
terminated133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_2
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
NCT00006037
completedphase_1
IM-862 in Treating Patients With Recurrent Ovarian Cancer
NCT00003773
unknownphase_2
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
NCT00017303
Clinical Trials (3)
Showing 3 of 3 trials
NCT00006037Phase 2
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
NCT00003773Phase 1
IM-862 in Treating Patients With Recurrent Ovarian Cancer
NCT00017303Phase 2
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3